CPT code 33273 represents the surgical repositioning of a previously implanted subcutaneous implantable defibrillator electrode. This procedure is clinically important because proper electrode positioning is essential for accurate arrhythmia detection and effective defibrillation therapy; repositioning can address lead migration, suboptimal sensing, or changes in clinical status. Nationally, revisions of implantable defibrillator leads are a focus for both clinical outcomes and billing clarity due to device-related complications and hospital resource use.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and typical settings, plus a summary of benchmark considerations and payer coverage patterns where available. The publication outlines billing and coding context, common modifiers associated with device procedures, and points of attention for claims processing and reimbursement workflows.

The content provides a national perspective useful to clinicians, coding professionals, and policy analysts seeking to understand where CPT code 33273 fits within device management practice, typical sites of service, and payer coverage frameworks. Data not available in the input will be identified explicitly in relevant sections.